Medvest is incorporated by two general partners in the UK with head offices in London and representative's in Tel-Aviv, Israel. Medvest is engaged with funding medical projects, joining professional teams and accompaning entrepreneurs for promising projects into their commercial status or pre-phase III clinical trials. MedVest is dependant on four partners and a professional consulting team which has built a strong reputation in recognizing, funding, guiding and closing technology deals for projects with capital needs from$100,000 to $1.5 million.
BioMed is considered the most powerful business sector in the 21st century. The expansion in healthcare spending, technology advancements and the unmet medical needs for cures, treatments and preventive medicine will continue to provide the biotech sector with exponential growth rates and advancements, not to mention lucrative investment opportunities.
News & Events
Mr. David Akunis will be attending MEIDCA, the premier event for the medical industrial sector. ComPaMed will be held in Düsseldorf, Germany between November 14-17, 2012. With over 500 international health care and top domestic companies expected to become part of this event and will also be the hub of over 5026 exhibitors.. We invite any interested parties to meet with David for any business opportunities at the exhibition. Look forward to seeing you there!!